Abstract: The present invention relates to a method for producing dendritic cells and their use in medicaments by genetic engineering aimed at functionally improving their therapeutic efficacy in the treatment of cancer, microbial infections, allergies, auto-immune diseases or organ and stem cell transplant rejection.
Type:
Grant
Filed:
December 12, 2008
Date of Patent:
April 5, 2016
Assignee:
TRIMED BIOTECH GMBH
Inventors:
Thomas Felzmann, Alexander Michael Dohnal
Abstract: The present invention relates to a method for producing dendritic cells and their use in medicaments by genetic engineering aimed at functionally improving their therapeutic efficacy in the treatment of cancer, microbial infections, allergies, auto-immune diseases or organ and stem cell transplant rejection.
Type:
Application
Filed:
December 12, 2008
Publication date:
November 11, 2010
Applicant:
TRIMED BIOTECH GMBH
Inventors:
Thomas Felzmann, Alexander Michael Dohnal